Amber Lifesciences Pvt. Ltd. stands as a trusted Erythromycin manufacturer and a leading name in the global antibiotic and CMO-CDMO industry. Our flagship product, ERYNOX (Erythromycin), represents reliability, compliance, and world-class quality — delivering excellence from India to pharmaceutical partners across LATAM, MENA, and African markets. We provide a complete and end-to-end contract manufacturing solution that helps pharmaceutical companies maintain consistent antibiotic supply chains, meet stringent regulatory requirements, and achieve a competitive edge in global markets.
About ERYNOX – Amber LifeSciences’ Erythromycin Formulation
ERYNOX (Erythromycin) is a broad-spectrum macrolide antibiotic effective against various Gram-positive and select Gram-negative bacteria. It plays a vital role in treating respiratory tract infections, skin infections, and certain sexually transmitted diseases. Amber Lifesciences ensures pharmaceutical-grade purity, stability, and bioavailability in every batch of ERYNOX manufactured for export, adhering to strict global quality and compliance standards.
End-to-End Antibiotic CMO/CDMO Solutions
We provide fully integrated services designed to simplify your product lifecycle — from development to distribution — ensuring every stage aligns with global compliance and performance benchmarks.
Complete Regulatory & Documentation Support
- Expert assistance for product registration and dossier compilation (CTD/eCTD format).
- Support for market entry across LATAM, Africa, CIS, and Southeast Asia.
- Guidance on bioequivalence, stability studies, and pharmacovigilance compliance.
Advanced cGMP-Compliant Manufacturing
- Produced in WHO-GMP & ISO-certified facilities under stringent quality systems.
- Dedicated macrolide production lines to prevent cross-contamination.
- Full in-process control and validation per IP, USP, and BP pharmacopoeial standards.
Quality Assurance That Builds Trust
- Multi-stage inspection using validated analytical methods.
- Batch consistency, impurity profiling, and microbial purity verification.
- Zero-compromise policy on sterility, potency, and dissolution quality.
Tailored Export Packaging & Labeling
- Custom packaging designed for export stability and protection.
- Multi-language labeling compliant with LATAM, EU, and African market requirements.
- Climate-controlled storage and packaging ensure product integrity during transit.
Proven Global Supply Chain Network
- Strategic logistics partnerships for on-time global deliveries.
- Reliable distribution across Brazil, Mexico, Chile, Colombia, and Argentina.
- Streamlined documentation and export support (COA, COO, MSDS, COPP).
Why Choose Amber LifeSciences for Erythromycin Manufacturing?
| Key Strength | Description |
|---|---|
| Regulatory Excellence | Proven expertise in managing complex international product registrations. |
| Operational Agility | Flexible production volumes — from pilot-scale to large commercial batches. |
| Cost Efficiency | Optimized manufacturing processes for competitive, scalable pricing. |
| Global Partnerships | Long-term alliances with importers, government bodies, and distributors. |
| Sustainability | Commitment to environmentally responsible and energy-efficient production. |
Amber LifeSciences — A Global CMO You Can Trust
- Trusted Global Partner: Years of experience in antibiotic contract manufacturing and formulation development.
- Integrated Manufacturing & Documentation: Streamlined systems ensuring compliance and operational excellence.
- Reliable Export Solutions: Serving multinational companies, government tenders, and global distributors.
- Commitment to Accessibility: Delivering essential antibiotics with consistency, compliance, and cost-effectiveness.
Corrected Comprehensive Product Profile: ERYNOX (Erythromycin)
- Brand Name: ERYNOX
- Active Ingredient: Erythromycin
- Therapeutic Class: Macrolide Antibiotic
- Dosage Forms:
- Capsules: 250 mg, 500 mg (typical strengths)
- Oral Suspension / Syrup: 125 mg/5 mL, 250 mg/5 mL
- Tablets: 250 mg, 500 mg (if applicable)
- Dry Powder for Reconstitution: 125 mg/5 mL, 250 mg/5 mL
- Manufacturer and Marketer: Amber Lifesciences
- Regulatory / Quality Info: WHO-GMP compliant
Conclusion
Amber Lifesciences Pvt. Ltd. continues to set new benchmarks in global antibiotic manufacturing with its flagship product, ERYNOX (Erythromycin). Through WHO-GMP and ISO-certified facilities, we ensure unmatched quality, compliance, and reliability across every batch. As a trusted CMO-CDMO partner from India, Amber empowers pharmaceutical companies in LATAM, MENA, and African markets with seamless supply, comprehensive regulatory support, and superior manufacturing capabilities. Partner with Amber LifeSciences to strengthen your antibiotic portfolio and ensure global healthcare access built on trust, innovation, and quality.
Get in Touch:
Partner with Amber Lifesciences Pvt. Ltd. — your reliable Erythromycin CMO-CDMO and global antibiotic exporter from India.
